Wegovy 1.7mg Flextouch Pen

Wegovy 1.7 mg FlexTouch is a pre-filled, single-patient-use injectable pen containing semaglutide, a GLP-1 receptor agonist used for chronic weight management. The FlexTouch device is designed for easy, once-weekly self-injection under the skin.

Uses:

• Treatment of obesity in adults (BMI ≥30), or
• Overweight individuals (BMI ≥27) with at least one weight-related health condition such as:
  • Type 2 diabetes
  • High blood pressure
  • High cholesterol

Used alongside a reduced-calorie diet and increased physical activity.

Benefits:

• Supports and maintains significant weight loss
• Helps reduce appetite and improve control over eating
• Improves blood sugar levels and other metabolic health markers
• Convenient once-weekly injection
• FlexTouch pen offers simple and precise dosing

Side Effects:

Common side effects may include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Stomach pain
• Headache
• Fatigue

Serious (but less common) side effects:

• Inflammation of the pancreas (pancreatitis)
• Gallbladder problems (e.g., gallstones)
• Kidney problems
• Risk of thyroid tumors (especially medullary thyroid carcinoma)

Warning: Wegovy should not be used if you or a family member has a history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 .

Storage:

• Before use: Store pens in the refrigerator at 2°C to 8°C (36°F to 46°F)
• Do not freeze. Discard if frozen.
• Protect from light
• Keep out of reach of children